Transposon Insertion within the purL Gene Induces Biofilm Depletion in Escherichia coli ATCC 25922
Present Escherichia coli antibiofilm remedies comprise a mixture of antibiotics generally used towards planktonic cells, resulting in therapy failure. A greater understanding of the genes concerned in biofilm formation might facilitate the event of environment friendly and particular new antibiofilm remedies.
A complete of 2578 E. coli mutants have been generated by transposon insertion, of which 536 have been analysed on this examine. After sequencing, Tn263 mutant, categorised as low biofilm-former (LF) in contrast to the wild-type (wt) pressure (ATCC 25922), confirmed an interruption within the purL gene, concerned within the de novo purine biosynthesis pathway.
To elucidate the function of purL in biofilm formation, a knockout was generated displaying lowered manufacturing of curli fibres, resulting in an impaired biofilm formation. These situations have been restored by complementation of the pressure or addition of exogenous inosine. Proteomic and transcriptional analyses have been carried out to characterise the variations brought on by purL alterations.
13 proteins have been altered in contrast to wt. The corresponding genes have been analysed by qRT-PCR not solely within the Tn263 and wt, but additionally in medical strains with totally different biofilm exercise. General, this examine means that purL is important for biofilm formation in E. coli and may be thought of as a possible antibiofilm goal.

CCR5 (Ab-336) Antibody |
|
MBS858547-01mg |
MyBiosource |
0.1mg |
EUR 305 |
CCR5 (Ab-336) Antibody |
|
MBS858547-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
CCR5 (Ab-336) Antibody |
|
MBS858547-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
CCR5 (Ab-336) Antibody |
|
MBS858547-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
CCR5 (Ab-336) Antibody |
|
MBS858547-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
CCR5 (Ab-349) Antibody |
|
8B0062 |
AAT Bioquest |
50ug |
EUR 368 |
|
Description: CCR5 (Ab-349) Antibody |
CCR5 (Ab-349) Antibody |
|
E11-0062B |
EnoGene |
100μg |
EUR 225 |
|
Description: Available in various conjugation types. |
CCR5 (Ab-349) Antibody |
|
MBS854216-01mg |
MyBiosource |
0.1mg |
EUR 305 |
CCR5 (Ab-349) Antibody |
|
MBS854216-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
CCR5 (Ab-349) Antibody |
|
MBS854216-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
CCR5 (Ab-349) Antibody |
|
MBS854216-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
CCR5 (Ab-349) Antibody |
|
MBS854216-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
Anti-Hemoglobin (Human) Mouse Monoclonal Antibody - Library Pack |
|
190101 |
Genovis AB |
3 x 100ug |
EUR 398 |
Goat anti-Human IgG Fc, F(ab)'2 Fragment, DyLight® 488 conjugated, min, cross-reactivity to human IgA, IgM or IgG F(ab)'2 fragment |
|
AS16-3353 |
Agrisera AB |
0,5 mg |
EUR 196 |
TSH (beta) | thyroid stimulating hormone (Affinity purified, F(ab)2' fragment, goat antibody) |
|
AS10-1325 |
Agrisera AB |
0,5 mg |
EUR 532 |
Human purified IgG, F(ab)'2 fragment (2 mg) |
|
AS10-909 |
Agrisera AB |
2 mg |
EUR 220 |
Goat anti-Human IgM (µ chain), F(ab)'2 Fragment, min, cross-reactivity to IgG from human or mouse |
|
AS16-3371 |
Agrisera AB |
1,0 mg |
EUR 238 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to human IgG or IgA |
|
AS10-1298 |
Agrisera AB |
0,5 mg |
EUR 273 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human IgG or IgA |
|
AS10-959 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human IgG or IgA |
|
AS10-1090 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human IgG or IgA |
|
AS10-1287 |
Agrisera AB |
0,5 mg |
EUR 259 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human IgG or IgA |
|
AS10-979 |
Agrisera AB |
0,5 mg |
EUR 273 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, HRP conjugated, min,reactivity to human, mouse IgG |
|
AS10-1145 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Human IgM (µ chain), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human IgA+IgG |
|
AS10-1296 |
Agrisera AB |
1 mg |
EUR 233 |
Goat anti-Human IgG Fc, F(ab)'2 Fragment, min, cross-reactivity to Human IgA/IgM, Bovine, Horse, Mouse, Rabbit Serum |
|
AS16-3350 |
Agrisera AB |
0,5 mg |
EUR 216 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human, mouse IgG |
|
AS10-1234 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human IgG/serum |
|
AS10-1002 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human, mouse IgG |
|
AS10-1023 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human, mouse IgG |
|
AS10-1088 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human IgG/serum |
|
AS10-1189 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to human IgG/serum |
|
AS10-1193 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to human IgG/serum |
|
As10-1071 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to human IgG/serum |
|
AS10-981 |
Agrisera AB |
0,5 mg |
EUR 233 |
Anti-Human IgG Fc specific Antibody |
|
87003 |
Genovis AB |
1mg |
EUR 215 |
Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to human, mouse,Rat IgG |
|
AS10-1058 |
Agrisera AB |
0,5 mg |
EUR 246 |
Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to human, mouse,Rat IgG |
|
AS10-1065 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3459 |
Agrisera AB |
1,0 mg |
EUR 284 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, DyLight® 488 conjugated, min, cross-reactivity to human, mouse lgG |
|
AS10-1217 |
Agrisera AB |
0,5 mg |
EUR 259 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, DyLight® 550 conjugated, min, cross-reactivity to human, mouse lgG |
|
AS12-1980 |
Agrisera AB |
0,5 mg |
EUR 246 |
Goat anti-Rat IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human, mouse IgG |
|
AS10-1215 |
Agrisera AB |
1 mg |
EUR 233 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human IgG/serum |
|
AS10-961 |
Agrisera AB |
1 mg |
EUR 233 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovin, human, mouse IgG/serum |
|
AS10-1042 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum |
|
AS10-1146 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum |
|
AS10-1059 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum |
|
AS10-1153 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Mouse IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3461 |
Agrisera AB |
1,0 mg |
EUR 252 |
Rabbit anti-Goat IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to human, mouse,Rat IgG |
|
AS10-1077 |
Agrisera AB |
1 mg |
EUR 246 |
Rabbit anti-Human IgM (µ chain), F(ab)'2 Fragment |
|
AS16-3370 |
Agrisera AB |
1 mg |
EUR 250 |
Anti-Human Alpha Synuclein Mouse Monoclonal Antibody |
|
56624 |
Genovis AB |
100 ug |
EUR 357 |
Goat anti-Human IgG F(ab')2 Affinity purified, Unconjugated |
|
AS21-4573 |
Agrisera AB |
2 mg |
EUR 206 |
Goat anti-Human IgG F(ab')2 Affinity purified, Unconjugated |
|
AS21-4574 |
Agrisera AB |
2 mg |
EUR 206 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3441 |
Agrisera AB |
0,5 mg |
EUR 264 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3452 |
Agrisera AB |
0,5 mg |
EUR 284 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3456 |
Agrisera AB |
0,5 mg |
EUR 300 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3445 |
Agrisera AB |
0,5 mg |
EUR 300 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine, goat, human, rabbit, or rat IgG |
|
AS16-3468 |
Agrisera AB |
0,5 mg |
EUR 284 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, DyLight® 800 conjugated, min, cross-reactivity to human IgG or serum proteins |
|
AS12-2436 |
Agrisera AB |
0,5 mg |
EUR 220 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, Affinity purified, Unconjugated, min, cross-reactivity to bovine, human, mouse IgG/serum |
|
AS10-982 |
Agrisera AB |
1 mg |
EUR 190 |
Anti-Human Immunoglobulin Mouse Monoclonal Antibody - Library Pack |
|
145101 |
Genovis AB |
2 x 100ug |
EUR 265 |
Goat anti-Human IgG Fc, F(ab)'2 fragment, FITC conjugated |
|
AS10-1236 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, ALP conjugated min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3440 |
Agrisera AB |
0,5 mg |
EUR 257 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, FITC conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3463 |
Agrisera AB |
0,5 mg |
EUR 214 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, HRP conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3464 |
Agrisera AB |
0,5 mg |
EUR 183 |
Goat anti-Rabbit IgG (H&L), F(ab)'2 fragment, ALP (alkaline phosphatase) conjugated, min, cross-reactivity to bovine,human, mouse IgG/serum |
|
AS10-1017 |
Agrisera AB |
0,5 mg |
EUR 233 |
Goat anti-Human IgG Fc, Biotin conjugated, F(ab)'2 fragment |
|
AS10-806 |
Agrisera AB |
0,5 mg |
EUR 206 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, Biotin-conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3462 |
Agrisera AB |
0,5 mg |
EUR 238 |
Goat anti-Mouse IgG (H&L), F(ab)'2 fragment, TRITC conjugated, min, cross-reactivity to bovine, horse, human, pig or rabbit serum protein |
|
AS16-3465 |
Agrisera AB |
0,5 mg |
EUR 214 |
Rabbit Anti Human Cd195 (Ccr5) Polyclonal Antibody |
|
CPBT-65067RH |
Creative Diagnostics |
0.1 mg |
EUR 520.8 |
|
Description: Rabbit |
Goat anti-Rabbit IgG (H&L), F(ab)'2 Fragment, min, cross-reactivity to non-immunoglobulin rabbit serum proteins and human serum proteins |
|
AS16-3530 |
Agrisera AB |
1,0 mg |
EUR 203 |
CCR5 Antibody |
|
35367 |
SAB |
100ul |
EUR 479 |
CCR5 Antibody |
|
35367-100ul |
SAB |
100ul |
EUR 468 |
CCR5 Antibody |
|
24008-100ul |
SAB |
100ul |
EUR 468 |
CCR5 Antibody |
|
1112-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: CCR5 Antibody: Human immunodeficiency virus (HIV) and related virus require coreceptors, in addition to CD4, to infect target cells. Some G protein-coupled receptors including CCR5, CXCR4, CCR3, CCR2b and CCR8 in the chemokine receptor family, and four new human molecules GPR15, STRL33, GPR1 and V28 were recently identified as HIV coreceptors. Among them, CCR5 (CC-CKR-5) is a principal coreceptor for macrophage- and dual-tropic HIV-1 strains fusion and entry of human white blood cells. CCR5 is required for the infection by HIV-1, HIV-2, and SIV. The beta-chemokines RANTES, MIP-alpha and MIP-beta are the ligands for CCR5 and prevent infection by M-tropic HIV-1. CXC5 associates with the surface CD4-gp120 of HIV complex and leads to membrane fusion and virus entry of target cells. The amino-terminal domain and the extracellular loops of CCR5 serve as HIV biding sites. CCR5 messenger RNA is expressed in lymphoid organs and monocytes. |
CCR5 Antibody |
|
1112-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: CCR5 Antibody: Human immunodeficiency virus (HIV) and related virus require coreceptors, in addition to CD4, to infect target cells. Some G protein-coupled receptors including CCR5, CXCR4, CCR3, CCR2b and CCR8 in the chemokine receptor family, and four new human molecules GPR15, STRL33, GPR1 and V28 were recently identified as HIV coreceptors. Among them, CCR5 (CC-CKR-5) is a principal coreceptor for macrophage- and dual-tropic HIV-1 strains fusion and entry of human white blood cells. CCR5 is required for the infection by HIV-1, HIV-2, and SIV. The beta-chemokines RANTES, MIP-alpha and MIP-beta are the ligands for CCR5 and prevent infection by M-tropic HIV-1. CXC5 associates with the surface CD4-gp120 of HIV complex and leads to membrane fusion and virus entry of target cells. The amino-terminal domain and the extracellular loops of CCR5 serve as HIV biding sites. CCR5 messenger RNA is expressed in lymphoid organs and monocytes. |
CCR5 Antibody |
|
1-CSB-PA006993 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000 |
CCR5 Antibody |
|
1-CSB-PA006994 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000 |
CCR5 Antibody |
|
1-CSB-PA004844GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
CCR5 Antibody |
|
1-CSB-PA004844LA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:2000-1:10000, IF:1:50-1:200 |
Ccr5 Antibody |
|
1-CSB-PA004844LA01MO |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against Ccr5. Recognizes Ccr5 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA |
CCR5 Antibody |
|
1-CSB-PA265884 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
CCR5 Antibody |
|
B0061-100ul |
Assay Biotech |
100μl |
EUR 217 |
|
Description: CCR5 Rabbit Polyclonal Antibody |
CCR5 Antibody |
|
B0061-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
|
Description: CCR5 Rabbit Polyclonal Antibody |
CCR5 Antibody |
|
1-CSB-PA548882 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50 |
CCR5 Antibody |
|
CSB-PA572290- |
Cusabio |
each |
EUR 402 |
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CCR5 Antibody |
|
CSB-PA572290-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CCR5 Antibody |
|
1-CSB-PA792075 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against CCR5. Recognizes CCR5 from Human. This antibody is Unconjugated. Tested in the following application: WB.IHC, ELISA;WB:1:500-2000, IHC-p:1:50-300, ELISA:1:10000-20000 |
CCR5 Antibody |
|
E18-6339-1 |
EnoGene |
50μg/50μl |
EUR 145 |
|
Description: Available in various conjugation types. |
CCR5 Antibody |
|
E18-6339-2 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
CCR5 Antibody |
|
E301744 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
CCR5 Antibody |
|
E38PA5786 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
CCR5 Antibody |
|
E91298 |
EnoGene |
100ul |
EUR 255 |
|
Description: Available in various conjugation types. |
CCR5 Antibody |
|
MBS151384-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Ccr5 Antibody |
|
MBS1496521-005mg |
MyBiosource |
0.05mg |
EUR 190 |
Ccr5 Antibody |
|
MBS1496521-01mg |
MyBiosource |
0.1mg |
EUR 270 |
Ccr5 Antibody |
|
MBS1496521-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
CCR5 Antibody |
|
MBS5312535-01mg |
MyBiosource |
0.1mg |
EUR 975 |
CCR5 Antibody |
|
MBS5312535-5x01mg |
MyBiosource |
5x0.1mg |
EUR 4245 |
CCR5 antibody |
|
MBS5309897-005mg |
MyBiosource |
0.05mg |
EUR 485 |
CCR5 antibody |
|
MBS5309897-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2045 |
CCR5 Antibody |
|
MBS540460-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1855 |
CCR5 Antibody |
|
MBS7130537-01mL |
MyBiosource |
0.1mL |
EUR 270 |
CCR5 Antibody |
|
MBS7130537-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
CCR5 Antibody |
|
MBS7117990-005mg |
MyBiosource |
0.05mg |
EUR 150 |
CCR5 Antibody |
|
MBS7117990-01mg |
MyBiosource |
0.1mg |
EUR 190 |
CCR5 Antibody |
|
MBS7117990-5x01mg |
MyBiosource |
5x0.1mg |
EUR 845 |
CCR5 Antibody |
|
MBS7128684-005mL |
MyBiosource |
0.05mL |
EUR 190 |
CCR5 Antibody |
|
MBS7128684-01mL |
MyBiosource |
0.1mL |
EUR 270 |
CCR5 Antibody |
|
MBS7128684-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
CCR5 Antibody |
|
MBS7128685-005mL |
MyBiosource |
0.05mL |
EUR 190 |
CCR5 Antibody |
|
MBS7128685-01mL |
MyBiosource |
0.1mL |
EUR 270 |
CCR5 Antibody |
|
MBS7128685-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
CCR5 Antibody |
|
MBS7047837-005mg |
MyBiosource |
0.05mg |
EUR 190 |
CCR5 Antibody |
|
MBS7047837-01mg |
MyBiosource |
0.1mg |
EUR 270 |
CCR5 Antibody |
|
MBS7047837-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
CCR5 Antibody |
|
MBS7122864-005mg |
MyBiosource |
0.05mg |
EUR 150 |
CCR5 Antibody |
|
MBS7122864-01mg |
MyBiosource |
0.1mg |
EUR 190 |
CCR5 Antibody |
|
MBS7122864-5x01mg |
MyBiosource |
5x0.1mg |
EUR 845 |
CCR5 Antibody |
|
MBS7118954-005mg |
MyBiosource |
0.05mg |
EUR 150 |
CCR5 Antibody |
|
MBS7118954-01mg |
MyBiosource |
0.1mg |
EUR 190 |
CCR5 Antibody |
|
MBS7118954-5x01mg |
MyBiosource |
5x0.1mg |
EUR 845 |
CCR5 Antibody |
|
MBS9601908-01mL |
MyBiosource |
0.1mL |
EUR 260 |
CCR5 Antibody |
|
MBS9601908-02mL |
MyBiosource |
0.2mL |
EUR 305 |
CCR5 Antibody |
|
MBS9601908-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
CCR5 Antibody |
|
MBS8583476-01mL |
MyBiosource |
0.1mL |
EUR 305 |
CCR5 Antibody |
|
MBS8583476-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
CCR5 Antibody |
|
MBS8583476-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence rating as an exemplar
Goal: Ladies with early-stage, ER + breast most cancers are suggest to obtain genomic profiling exams, reminiscent of the 21-gene Recurrence Rating (RS) take a look at, to information therapy choices. We examined test- and treatment-related info mentioned and the associations between RS classes and elements of communication throughout patient-oncologist medical encounters.
Strategies: As half of a bigger trial, medical encounters (N = 46) have been audiorecorded and coded for 1) RS- and treatment-related info, 2) shared resolution making, 3) affected person energetic participation, and 4) oncologist patient-centered communication. We examined variations by RS class utilizing blended fashions, adjusting for nesting inside oncologist.
Outcomes: Sufferers with a excessive RS have been extra prone to obtain a chemotherapy suggestion (p < .01), hear concerning the dangers/unintended effects of chemotherapy (p < .01), and provide their preferences (p = .02) than these with intermediate or low RS. Parts of shared resolution making elevated with RS. Oncologist patient-centered communication (M = 4.09/5, SD = .25) and affected person energetic participation (M = 3.5/4, SD = 1.0) have been excessive throughout RS.
Conclusion: Findings counsel that illness severity, quite than medical uncertainty, impression therapy suggestions and shared resolution making.
Observe implications: Oncologists modify test- and treatment-related info and shared resolution making by illness severity. This info supplies a framework to tell resolution making in complicated most cancers and genomics settings.
CRISPR-Cas, a sturdy gene-editing know-how within the period of contemporary most cancers immunotherapy
Most cancers immunotherapy has been emerged as a promising technique for therapy of a broad spectrum of malignancies starting from hematological to strong tumors. One of many principal approaches of most cancers immunotherapy is switch of pure or engineered tumor-specific T-cells into sufferers,
a so referred to as “adoptive cell switch”, or ACT, course of. Building of allogeneic T-cells relies on the employment of a gene-editing software to change donor-extracted T-cells and put together them to particularly act towards tumor cells with enhanced perform and sturdiness and least side-effects. On this context, CRISPR know-how can be utilized to supply common T-cells, geared up with recombinant T cell receptor (TCR) or chimeric antigen receptor (CAR), by means of multiplex genome engineering utilizing Cas nucleases.
The sturdy potential of CRISPR-Cas in making ready the constructing blocks of ACT immunotherapy has broaden the appliance of such therapies and a few of them have gotten FDA approvals. Right here, now we have collected the final investigations within the discipline of immuno-oncology performed in partnership with CRISPR know-how. As well as, research which have addressed the challenges within the path of CRISPR-mediated most cancers immunotherapy, in addition to pre-treatment purposes of CRISPR-Cas have been talked about intimately.
CBLL1 Antibody |
|
E93502 |
EnoGene |
100μg |
EUR 255 |
|
Description: Available in various conjugation types. |
CBLL1 Antibody |
|
MBS9611328-01mL |
MyBiosource |
0.1mL |
EUR 260 |
CBLL1 Antibody |
|
MBS9611328-02mL |
MyBiosource |
0.2mL |
EUR 305 |
CBLL1 Antibody |
|
MBS9611328-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
CBLL1 Antibody |
|
MBS8506037-01mg |
MyBiosource |
0.1mg |
EUR 325 |
CBLL1 Antibody |
|
MBS8506037-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
CBLL1 Antibody |
|
MBS8506037-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
CBLL1 Antibody |
|
MBS8506037-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
CBLL1 Antibody |
|
MBS8506037-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
CBLL1 antibody |
|
MBS833715-01mL |
MyBiosource |
0.1mL |
EUR 660 |
CBLL1 antibody |
|
MBS833715-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2820 |
anti- CBLL1 antibody |
|
FNab01320 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against CBLL1 |
CBLL1 Polyclonal Antibody |
|
28768 |
SAB |
100ul |
EUR 439 |
CBLL1 Polyclonal Antibody |
|
28768-100ul |
SAB |
100ul |
EUR 302.4 |
CBLL1 Polyclonal Antibody |
|
28768-50ul |
SAB |
50ul |
EUR 224.4 |
CBLL1 Polyclonal Antibody |
|
E914932 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
CBLL1 Polyclonal Antibody |
|
MBS9134923-002mL |
MyBiosource |
0.02mL |
EUR 200 |
CBLL1 Polyclonal Antibody |
|
MBS9134923-005mL |
MyBiosource |
0.05mL |
EUR 255 |
CBLL1 Polyclonal Antibody |
|
MBS9134923-01mL |
MyBiosource |
0.1mL |
EUR 345 |
CBLL1 Polyclonal Antibody |
|
MBS9134923-02mL |
MyBiosource |
0.2mL |
EUR 545 |
CBLL1 Polyclonal Antibody |
|
MBS9134923-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2265 |
CBLL1 Polyclonal Antibody |
|
MBS8569621-01mL |
MyBiosource |
0.1mL |
EUR 305 |
CBLL1 Polyclonal Antibody |
|
MBS8569621-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
CBLL1 Polyclonal Antibody |
|
MBS8569621-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
CBLL1 Polyclonal Antibody |
|
MBS8569621-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
CBLL1 Polyclonal Antibody |
|
MBS8569621-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
CBLL1 Polyclonal Antibody |
|
MBS9432362-005mL |
MyBiosource |
0.05mL |
EUR 300 |
CBLL1 Polyclonal Antibody |
|
MBS9432362-01mL |
MyBiosource |
0.1mL |
EUR 390 |
CBLL1 Polyclonal Antibody |
|
MBS9432362-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1610 |
Cbll1 antibody - C-terminal region |
|
MBS3201622-01mL |
MyBiosource |
0.1mL |
EUR 455 |
Cbll1 antibody - C-terminal region |
|
MBS3201622-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
CBLL1 antibody - N-terminal region |
|
MBS3201623-01mL |
MyBiosource |
0.1mL |
EUR 455 |
CBLL1 antibody - N-terminal region |
|
MBS3201623-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
CBLL1 antibody - N-terminal region |
|
MBS3204745-01mL |
MyBiosource |
0.1mL |
EUR 455 |
CBLL1 antibody - N-terminal region |
|
MBS3204745-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
CBLL1 antibody - C-terminal region |
|
MBS3204746-01mL |
MyBiosource |
0.1mL |
EUR 400 |
CBLL1 antibody - C-terminal region |
|
MBS3204746-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1760 |
CBLL1 Polyclonal Conjugated Antibody |
|
C28768 |
SAB |
100ul |
EUR 476.4 |
CBLL1 Polyclonal Conjugated Antibody |
|
MBS9440366-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
CBLL1 Polyclonal Conjugated Antibody |
|
MBS9440366-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
CBLL1 Polyclonal Conjugated Antibody |
|
MBS9440366-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
CBLL1 Polyclonal Conjugated Antibody |
|
MBS9440366-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
CBLL1 Polyclonal Conjugated Antibody |
|
MBS9440366-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
Polyclonal CBLL1 antibody - N-terminal region |
|
APR00636G |
Leading Biology |
0.05mg |
EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CBLL1 - N-terminal region. This antibody is tested and proven to work in the following applications: |
Polyclonal CBLL1 antibody - N-terminal region |
|
APR00763G |
Leading Biology |
0.05mg |
EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CBLL1 - N-terminal region. This antibody is tested and proven to work in the following applications: |
Polyclonal CBLL1 antibody - C-terminal region |
|
APR00764G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CBLL1 - C-terminal region. This antibody is tested and proven to work in the following applications: |
CBLL1 |
|
CSB-CL755210HU |
Cusabio |
10 μg plasmid + 200μl Glycerol |
Ask for price |
E3 Ubiquitin-Protein Ligase Hakai (CBLL1) Antibody |
|
abx111412-100l |
Abbexa |
100 µl |
EUR 612.5 |
E3 Ubiquitin-Protein Ligase Hakai (CBLL1) Antibody |
|
20-abx111412 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Monoclonal CBLL1 Antibody (monoclonal) (M01), Clone: 4C2 |
|
AMM03326G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A Monoclonal antibody against Human CBLL1 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 4C2. This antibody is applicable in WB and IF |
E3 Ubiquitin-Protein Ligase Hakai (CBLL1) Antibody |
|
abx231320-100g |
Abbexa |
100 µg |
EUR 350 |
E3 Ubiquitin-Protein Ligase Hakai (CBLL1) Antibody |
|
abx231320-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
|
ARP39622_P050-25UL - CBLL1 Antibody - N-terminal region |
|
ARP39622_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
|
ARP39623_T100-25UL - CBLL1 Antibody - C-terminal region |
|
ARP39623_T100-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
|
ARP33600_P050-25UL - Cbll1 Antibody - C-terminal region |
|
ARP33600_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
|
ARP33601_P050-25UL - CBLL1 Antibody - N-terminal region |
|
ARP33601_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
|
ARP39622_P050 - CBLL1 antibody - N-terminal region (ARP39622_P050) |
|
ARP39622_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
|
ARP39623_T100 - CBLL1 antibody - C-terminal region (ARP39623_T100) |
|
ARP39623_T100 |
Aviva Systems Biology |
100ul |
EUR 339 |
|
|
ARP33600_P050 - Cbll1 antibody - C-terminal region (ARP33600_P050) |
|
ARP33600_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
|
ARP33601_P050 - CBLL1 antibody - N-terminal region (ARP33601_P050) |
|
ARP33601_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
|
CBLL1 Peptide |
|
MBS3229711-01mg |
MyBiosource |
0.1mg |
EUR 180 |
CBLL1 Peptide |
|
MBS3229711-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
CBLL1 Rabbit pAb |
|
A14932 |
Abclonal |
200μL |
EUR 173.58 |
CBLL1 Rabbit pAb |
|
A14932-100ul |
Abclonal |
100 ul |
EUR 369.6 |
CBLL1 Rabbit pAb |
|
A14932-200ul |
Abclonal |
200 ul |
EUR 550.8 |
CBLL1 Rabbit pAb |
|
A14932-20ul |
Abclonal |
20 ul |
EUR 219.6 |
CBLL1 Rabbit pAb |
|
A14932-50ul |
Abclonal |
50 ul |
EUR 267.6 |
CBLL1 cDNA Clone |
|
MBS1266698-001mgPlasmid02mLGlycerolStock |
MyBiosource |
0.01mgPlasmid+0.2mLGlycerol-Stock |
EUR 485 |
CBLL1 cDNA Clone |
|
MBS1266698-5x001mgPlasmid5x02mLGlycerolStock |
MyBiosource |
5x0.01mgPlasmid+5x0.2mLGlycerol-Stock |
EUR 2145 |
CBLL1 Rabbit pAb |
|
E45R21486N |
EnoGene |
50 ul |
EUR 297.75 |
Mouse CBLL1 siRNA |
|
20-abx910399 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Human CBLL1 siRNA |
|
20-abx910400 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
CBLL1 siRNA (Human) |
|
MBS829115-15nmol |
MyBiosource |
15nmol |
EUR 405 |
CBLL1 siRNA (Human) |
|
MBS829115-30nmol |
MyBiosource |
30nmol |
EUR 565 |
CBLL1 siRNA (Human) |
|
MBS829115-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
CBLL1 siRNA (Mouse) |
|
MBS828168-15nmol |
MyBiosource |
15nmol |
EUR 405 |
CBLL1 siRNA (Mouse) |
|
MBS828168-30nmol |
MyBiosource |
30nmol |
EUR 565 |
CBLL1 siRNA (Mouse) |
|
MBS828168-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
CBLL1 cloning plasmid |
|
CSB-CL755210HU-10ug |
Cusabio |
10ug |
EUR 627.6 |
|
|
|
Description: A cloning plasmid for the CBLL1 gene. |
CBLL1 Blocking Peptide |
|
DF12576-BP |
Affbiotech |
1mg |
EUR 234 |
CBLL1 Blocking Peptide |
|
MBS9621281-1mg |
MyBiosource |
1mg |
EUR 380 |
CBLL1 Blocking Peptide |
|
MBS9621281-5x1mg |
MyBiosource |
5x1mg |
EUR 1650 |
Recombinant Human CBLL1 |
|
MBS7615930-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human CBLL1 |
|
MBS7615930-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human CBLL1 |
|
MBS7615930-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human CBLL1 |
|
MBS7615930-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Cbll1 (untagged) - Mouse Casitas B-lineage lymphoma-like 1 (Cbll1), (10ug) |
|
MC216776 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Mouse CBLL1 shRNA Plasmid |
|
20-abx979665 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Human CBLL1 shRNA Plasmid |
|
20-abx962629 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Human CBLL1 Protein Lysate |
|
MBS138729-002mg |
MyBiosource |
0.02mg |
EUR 545 |
Human CBLL1 Protein Lysate |
|
MBS138729-5x002mg |
MyBiosource |
5x0.02mg |
EUR 2225 |
Cbll1 (Myc-DDK-tagged) - Mouse Casitas B-lineage lymphoma-like 1 (Cbll1) |
|
MR207838 |
Origene Technologies GmbH |
10 µg |
Ask for price |
CBLL1 Recombinant Protein (Rat) |
|
RP193286 |
ABM |
100 ug |
Ask for price |
Recombinant Human CBLL1 Protein |
|
E30P65870A |
EnoGene |
50 ug |
EUR 295 |
CBLL1 Recombinant Protein (Human) |
|
RP037747 |
ABM |
100 ug |
Ask for price |
CBLL1 Recombinant Protein (Mouse) |
|
RP121400 |
ABM |
100 ug |
Ask for price |
CBLL1 Recombinant Protein (Mouse) |
|
RP121403 |
ABM |
100 ug |
Ask for price |
CBLL1 Recombinant Protein (Mouse) |
|
RP121406 |
ABM |
100 ug |
Ask for price |
Cbll1 ORF Vector (Rat) (pORF) |
|
ORF064430 |
ABM |
1.0 ug DNA |
EUR 607.2 |
CBLL1 ORF Vector (Human) (pORF) |
|
ORF012583 |
ABM |
1.0 ug DNA |
EUR 424.8 |
Cbll1 ORF Vector (Mouse) (pORF) |
|
ORF040468 |
ABM |
1.0 ug DNA |
EUR 1886.4 |
Cbll1 ORF Vector (Mouse) (pORF) |
|
ORF040469 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Cbll1 ORF Vector (Mouse) (pORF) |
|
ORF040470 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Cbll1 (untagged) - Mouse Casitas B-lineage lymphoma-like 1 (Cbll1), transcript variant 3 |
|
MC227084 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Cbll1 (untagged) - Mouse Casitas B-lineage lymphoma-like 1 (Cbll1), transcript variant 1 |
|
MC227985 |
Origene Technologies GmbH |
10 µg |
Ask for price |
CBLL1 (NM_024814) Human Over-expression Lysate |
|
E45H12150-2 |
EnoGene |
each |
EUR 395 |
CBLL1 (NM_024814) Human Over-expression Lysate |
|
LS079872 |
BosterBio |
100ug |
EUR 960 |
|
|
|
Description: Transient overexpression lysate of Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (CBLL1), transcript variant 1 |
Human CBLL1 Protein Lysate 20ug |
|
IHUCBLL1PLLY20UG |
Innovative research |
each |
EUR 361 |
|
|
|
Description: Human CBLL1 Protein Lysate 20ug |
CBLL1 Peptide - N-terminal region |
|
MBS3229710-01mg |
MyBiosource |
0.1mg |
EUR 180 |
CBLL1 Peptide - N-terminal region |
|
MBS3229710-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
Cbll1 Peptide - C-terminal region |
|
MBS3226630-01mg |
MyBiosource |
0.1mg |
EUR 180 |
Cbll1 Peptide - C-terminal region |
|
MBS3226630-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
CBLL1 Peptide - N-terminal region |
|
MBS3226631-01mg |
MyBiosource |
0.1mg |
EUR 180 |
CBLL1 Peptide - N-terminal region |
|
MBS3226631-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |